首页>
美国卫生研究院文献>Therapeutic Advances in Hematology
>Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score–matched cohort analysis
【2h】
Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score–matched cohort analysis
展开▼
机译:与常规化疗相比blinatumomab 对复发或难治性 B 细胞前体急性淋巴细胞白血病成年患者的生存结局更好:倾向评分匹配的队列分析